Rockville, MD, United States of America

Keith Webber

This inventor holds 1 USPTO granted patent. Top assignee: Regenxbio Inc.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Keith Webber. Retrieved from https://idiyas.com/inventor/keith-webber

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Keith Webber and Spectrophotometry for AAV Analysis

Introduction

Keith Webber is an inventor based in Rockville, Maryland, United States. His patent work concerns spectrophotometric methods for analyzing adeno-associated virus (AAV) particles, including estimating genome copies and determining full-to-empty particle ratios.

Latest Patents

Webber is associated with 1 patent: “Systems and Methods of Spectrophotometry for the Determination of Genome Content, Capsid Content and Full/Empty Ratios of Adeno-Associated Virus Particles.” The disclosure describes using spectrophotometry to estimate genome copies and assess the proportions of full and empty AAV particles.

Career Highlights

Webber is associated with Regenxbio Inc. His listed patent reflects work on analytical approaches relevant to characterizing AAV particles.

Collaborations

The provided information lists Zhuchun Wu and Brian Howie as Webber’s coworkers. Their names are associated here as professional collaborators, though specific roles in the patent are not provided.

Conclusion

Keith Webber’s listed invention focuses on applying spectrophotometry to measure genome content and evaluate full-to-empty ratios in AAV particles, in connection with his work at Regenxbio Inc.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…